Socioeconomic Inequalities in the Mortality of Hodgkin and Non-Hodgkin Lymphoma: A Two-Decade Trend Analysis.

Simple Summary: Despite significant medical advancements, lymphomas remain a leading cause of cancer-related illness and death in Canada. While mortality from Hodgkin lymphoma has generally decreased, deaths from non-Hodgkin lymphoma did not decline in Canada. Importantly, this study shows that thes...

Descripción completa

Detalles Bibliográficos
Publicado en:Current Oncology Vol. 33; no. 8; pp. 470 - 486
Autores principales: Zhang, Kelly, Kiadaliri, Ali, Hajizadeh, Mohammad
Formato: Journal Article
Publicado: MDPI Aug2026
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:Simple Summary: Despite significant medical advancements, lymphomas remain a leading cause of cancer-related illness and death in Canada. While mortality from Hodgkin lymphoma has generally decreased, deaths from non-Hodgkin lymphoma did not decline in Canada. Importantly, this study shows that these deaths are not distributed equally; individuals with lower incomes and less education face a higher risk of dying from these cancers. These disparities have increased over time, with the burden of non-Hodgkin lymphoma increasingly concentrated among the most socioeconomically disadvantaged populations. These findings suggest that medical breakthroughs alone are not sufficient to ensure survival for everyone. To improve outcomes, future health policies should focus on reducing these systemic barriers by ensuring that life-saving cancer treatments and early detection programs are equally accessible to all Canadians, regardless of socioeconomic status. Lymphomas are broadly categorized into Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL). Despite treatment advances, they remain a major cause of cancer-related morbidity and mortality in Canada. This study examined temporal trends in socioeconomic inequalities in lymphoma mortality in Canada from 2000 to 2019. Using a unique census division level dataset (n = 280) constructed by pooling information from the Canadian Vital Statistics Death Database, the Canadian Census of Population and the National Household Survey, we measured mortality in HL and NHL in Canada. The age-standardized Concentration index (C) was used to quantify income and education inequalities in lymphoma. Time trend analyses were conducted to examine the changes in the observed socioeconomic inequalities. Crude HL mortality declined significantly over the study period. Crude NHL mortality remained largely unchanged in Canada overall, although modest declines were observed in the Prairies. The age-standardized C indicated persistent income and education inequalities for both lymphoma types. For NHL, mortality became increasingly concentrated among lower-income and lower-education populations over time. The persistent and widening socioeconomic inequalities observed in HL and NHL mortality, respectively, in Canada underscore the need for targeted public health interventions and more equitable distribution of resources to address systematic and avoidable differences in cancer outcomes associated with socioeconomic disadvantage.